Half of all rare-disease patients are children, and their families have long pushed to speed up cures. Now, some families are forming their own biotech businesses.
CDC reports that infections unfazed by oral antibiotics expanded their range during the first year of the COVID-19 pandemic.
Get the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.